TIL · Instil Bio, Inc.
What's happening
- TIL is up 4.27% today, trading at $6.10. — Live quote
- Volume today (121) is well below its 3-month average of 17,420. (Finnhub fundamentals)
- Reports earnings on 2026-11-11, 20 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-0.63 actual vs. $-0.43 estimated (-45.1%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Aggregate ratings for 2026-10-01 (8 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
Earnings Trends (Quarterly EPS Actual vs Estimate)
Valuation Measures & Ratios
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $51.9M | $56.3M | $121.3M | $139.1M | $74.9M |
| P/E | -1.19 | -0.84 | -1.41 | -1.59 | -0.83 |
| Price/Book | 0.48 | 0.51 | 1.01 | 1.06 | 0.52 |
| EV/EBITDA | -0.91 | -0.68 | -1.27 | — | — |
| ROE | -40.50% | -60.87% | -71.58% | -66.48% | -62.41% |
| ROA | -21.99% | -33.62% | -40.71% | -37.89% | -38.09% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 10-Q, filed 2026-08-13; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Trailing 52-week price return is -70.6%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on TIL
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Operating income | -$5.6M | -$7.0M | -$15.0M | -$23.4M | -$30.6M | -$23.6M | -$14.1M | -$24.0M |
| Net income | -$4.3M | -$4.2M | -$13.6M | -$21.4M | -$28.2M | -$23.0M | -$14.9M | -$24.3M |
| EPS (diluted) | $-0.63 | $-0.62 | $-2.01 | $-3.24 | $-4.32 | $-3.54 | $-2.29 | $-3.74 |
| EPS (basic) | $-0.63 | $-0.62 | $-2.01 | $-3.24 | $-4.32 | $-3.54 | $-2.29 | $-3.74 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $197.7M | $200.4M | $203.5M | $211.8M | $231.0M | $237.4M | $263.6M | $272.6M |
| Total liabilities | $90.3M | $89.7M | $89.7M | $91.3M | $99.3M | $92.5M | $94.1M | $96.2M |
| Stockholders' equity | $107.4M | $110.7M | $113.9M | $120.4M | $131.7M | $144.9M | $169.4M | $176.3M |
| Total current assets | $71.6M | $188.3M | $191.4M | $196.3M | $207.4M | $219.3M | $124.5M | $132.6M |
| Total current liabilities | $3.3M | $4.7M | $4.8M | $5.7M | $13.9M | $7.2M | $7.9M | $10.3M |
| Cash & equivalents | $5.5M | $5.0M | $6.6M | $5.8M | $7.7M | $15.4M | $8.8M | $6.7M |
| Marketable securities (current) | — | — | — | — | — | — | — | — |
| Other current assets | $76.0K | $143.0K | $148.0K | $164.0K | $154.0K | $192.0K | $959.0K | $2.0M |
| Marketable securities (non-current) | — | — | — | $3.4M | $11.7M | $7.2M | $0 | $2.6M |
| Property, plant & equipment | $111.8M | $112.0K | $126.0K | $138.0K | $150.0K | $162.0K | $129.4M | $130.1M |
| Goodwill | — | — | — | — | — | — | — | — |
| Other non-current assets | $3.9M | $4.0M | $4.1M | $4.1M | $11.2M | $10.1M | $4.5M | $6.2M |
| Accounts payable | $795.0K | $793.0K | $779.0K | $928.0K | $523.0K | $286.0K | $659.0K | $1.2M |
| Other current liabilities | — | — | — | — | — | — | $0 | $107.0K |
| Other non-current liabilities | $0 | $8.0K | $8.0K | $88.0K | $90.0K | $85.0K | $83.0K | $8.0K |
| Common stock & paid-in capital | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Retained earnings | -$735.0M | -$730.7M | -$726.5M | -$718.3M | -$704.7M | -$683.3M | -$655.1M | -$643.2M |
| Accumulated other comprehensive income (loss) | -$587.0K | -$532.0K | -$583.0K | -$612.0K | -$805.0K | -$451.0K | -$228.0K | -$520.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$4.6M | -$1.3M | -$7.1M | -$10.6M | -$14.8M | -$4.2M | -$10.6M | -$20.1M |
| Investing cash flow | $5.3M | -$317.0K | $7.8M | $8.4M | -$400.0K | $9.6M | $13.0M | $19.8M |
| Financing cash flow | $0 | $0 | $0 | $378.0K | $6.7M | $232.0K | $1.6M | $159.0K |
| Free cash flow | — | — | — | — | — | — | -$10.6M | -$20.1M |
| Capital expenditures | — | — | — | — | — | — | $0 | $0 |
| Depreciation & amortization | $248.0K | $12.0K | $12.0K | $12.0K | $12.0K | $498.0K | $741.0K | $901.0K |
| Share-based compensation | $1.0M | $985.0K | $1.6M | $1.8M | $1.8M | $3.5M | $4.5M | $4.1M |
| Deferred income taxes | — | — | — | — | — | — | — | — |
| Change in accounts payable | $0 | $17.0K | -$148.0K | $403.0K | $237.0K | -$376.0K | -$522.0K | -$45.0K |
| Purchases of investments | $17.5M | $22.3M | $17.4M | $6.6M | $38.7M | $38.2M | $27.3M | $15.6M |
| Sales/maturities of investments | $22.8M | $22.0M | $25.2M | $25.0M | $38.3M | $47.4M | $39.4M | $47.0M |
| Other financing activities | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | $0 |
| Operating income | -$78.6M | -$73.5M | -$159.2M | -$226.5M | -$155.6M |
| Net income | -$71.4M | -$74.1M | -$156.1M | -$223.2M | -$156.8M |
| EPS (diluted) | $-10.70 | $-11.39 | $-24.00 | $-34.46 | $-1.48 |
| EPS (basic) | $-10.70 | $-11.39 | $-24.00 | $-34.46 | $-1.48 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $203.5M | $263.6M | $325.6M | $482.1M | $610.0M |
| Total liabilities | $89.7M | $94.1M | $99.8M | $118.5M | $54.8M |
| Stockholders' equity | $113.9M | $169.4M | $225.8M | $363.6M | $555.2M |
| Total current assets | $191.4M | $124.5M | $160.8M | $269.4M | $464.0M |
| Total current liabilities | $4.8M | $7.9M | $10.6M | $32.8M | $41.4M |
| Cash & equivalents | $6.6M | $8.8M | $9.2M | $43.7M | $37.6M |
| Marketable securities (current) | — | — | $141.2M | $217.2M | $416.5M |
| Other current assets | $148.0K | $959.0K | $2.6M | — | — |
| Marketable securities (non-current) | — | $0 | $23.2M | $0 | — |
| Property, plant & equipment | $126.0K | $129.4M | $138.7M | $196.9M | $122.0M |
| Goodwill | — | — | — | $0 | $5.7M |
| Other non-current assets | $4.1M | $4.5M | $639.0K | $3.4M | $8.1M |
| Accounts payable | $779.0K | $659.0K | $1.2M | $2.4M | $5.6M |
| Other current liabilities | — | $0 | $190.0K | $592.0K | $386.0K |
| Other non-current liabilities | $8.0K | $83.0K | $80.0K | $332.0K | $20.0K |
| Common stock & paid-in capital | $0 | $0 | $0 | $0 | $0 |
| Retained earnings | -$726.5M | -$655.1M | -$581.0M | -$424.9M | -$201.7M |
| Accumulated other comprehensive income (loss) | -$583.0K | -$228.0K | -$348.0K | -$493.0K | -$87.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$36.6M | -$55.7M | -$82.0M | -$180.2M | -$122.1M |
| Investing cash flow | $25.5M | $54.0M | $41.1M | $114.5M | -$474.4M |
| Financing cash flow | $7.3M | $1.8M | $8.1M | $71.9M | $393.2M |
| Free cash flow | — | -$55.7M | -$102.7M | -$264.8M | -$180.0M |
| Capital expenditures | — | $0 | $20.7M | $84.6M | $57.8M |
| Depreciation & amortization | $534.0K | $3.6M | $4.8M | $6.0M | $2.8M |
| Share-based compensation | $8.7M | $17.3M | $18.2M | $30.4M | $26.2M |
| Deferred income taxes | — | — | $0 | -$2.1M | $39.0K |
| Change in accounts payable | $116.0K | -$556.0K | -$1.1M | -$1.8M | $3.9M |
| Purchases of investments | $100.9M | $134.0M | $301.5M | $665.0M | $1.11B |
| Sales/maturities of investments | $135.9M | $198.1M | $361.7M | $865.4M | $691.0M |
| Other financing activities | — | — | — | $0 | -$69.0K |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding TIL as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-09-10 to 2025-09-10
Recent transactions
- Most recent: Laumas Sandeep (CFO and CBO) — Option exercise of 17,000 shares on 2025-09-10.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Laumas Sandeep | CFO and CBO | Option exercise | 2025-09-10 | 17,000 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2025-09-10 | Laumas Sandeep | CFO and CBO | Option exercise | 17,000 | $11.60 |
| 2025-09-10 | Laumas Sandeep | CFO and CBO | Option exercise | 13,000 | $12.68 |
| 2025-09-10 | Laumas Sandeep | CFO and CBO | Open market sale | 17,539 | $23.04 |
| 2025-09-10 | Laumas Sandeep | CFO and CBO | Open market sale | 12,461 | $23.88 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-21 23:46 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-13 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-13 | 8-K | 2026-08-13 | View on SEC.gov → |
| 2026-06-12 | 4 | 2026-06-11 | View on SEC.gov → |
| 2026-06-12 | 4 | 2026-06-11 | View on SEC.gov → |
| 2026-06-12 | 4 | 2026-06-11 | View on SEC.gov → |
| 2026-06-12 | 4 | 2026-06-11 | View on SEC.gov → |
| 2026-06-11 | 8-K | 2026-06-11 | View on SEC.gov → |
| 2026-05-15 | 10-Q | 2026-03-31 | View on SEC.gov → |
| 2026-05-15 | 8-K | 2026-05-15 | View on SEC.gov → |
| 2026-04-03 | 8-K | 2026-04-01 | View on SEC.gov → |
| 2026-03-27 | 10-K | 2025-12-31 | View on SEC.gov → |
| 2026-03-27 | 8-K | 2026-03-27 | View on SEC.gov → |
Recent news
Headlines about TIL (Instil Bio, Inc.). Links open the publisher — we don’t host full articles.
-
Tilray hits 52-week low: Can TLRY recover in the near term?
Traders Union · 2026-10-21 -
Tilray Brands, Inc. (TLRY.TO) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-21 -
Tilray Brands, Inc. (TLRY) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-21 -
Overblik over finanshusenes forventning til dagens rentemelding fra FED: 44% ser en renteforhøjelse
Økonomisk Ugebrev · 2026-10-19 -
Cindy Crawford Breaks Silence On Tragic Death Of Son Presley Gerber: 'Til We Meet Again'
Perez Hilton · 2026-10-19 -
Cindy Crawford Shares Heartbreaking Tribute to Son Presley: “Til We Meet Again Our Sweet Boy”
Wide Open Country · 2026-10-19 -
Iovance Highlights TIL Cell Therapy Platform Across Solid Tumors at the European Society for Medical Oncology (ESMO) Congress 2026
Yahoo Finance · 2026-10-19 -
Cindy Crawford Breaks Silence on Death of Son Presley Gerber: ‘Til We Meet Again Our Sweet Boy’
TODAY.com · 2026-10-18
No headlines in this category right now — try “All”.